New decision tool aims to reduce aggressive End-of-Life cancer care

NCT ID NCT04823377

Ongoing Knowledge-focused Sponsor: Institut Curie Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at whether a special decision-making tool can help doctors and patients with advanced non-small cell lung cancer decide when to stop cancer treatments. The goal is to reduce the number of patients receiving chemotherapy or other treatments in their last days of life, which can be harsh and offer little benefit. The study compares usual care to a period where the tool is used, involving 364 participants.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this could provide a reliable way to help doctors and patients decide when to stop cancer treatments, potentially improving quality of life at the end of life.
What could go wrong: This is an observational-style study comparing two time periods, not a randomized trial, so results may be influenced by other changes over time. It does not test a new drug or treatment.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cancer non-small cell lung carcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ADVANCED CANCER CARCINOMA, NON-SMALL-CELL LUNG

Contacts and locations

Locations

AP-HP Ambroise Paré

Boulogne-Billancourt, 92100, France
AP-HP Bichat

Paris, 75018, France
AP-HP Cochin

Paris, 75014, France
AP-HP Tenon

Paris, 75970, France
CGFL

Dijon, 21000, France
CH Abbeville

Abbeville, 80142, France
CH Henri Duffaut Avignon

Avignon, 84000, France
CH Intercommunal de Créteil

Créteil, 94000, France
CH Saint-Malo

St-Malo, 35420, France
CH du Pays d'Aix

Aix-en-Provence, 13616, France
CHD Vendée

La Roche-sur-Yon, 85925, France
CHI de Compiègne-Noyon

Compiègne, 60200, France
CHR Metz-Thionville - Hôpital de Mercy

Ars-Laquenexy, France
CHRU Lille

Lille, 59000, France
CHU Amiens - Hôpital Sud

Amiens, 80054, France
CHU Angers

Angers, 49933, France
CHU Grenoble Alpes

Grenoble, 38043, France
CHU Sud Francilien

Corbeil-Essonnes, 91100, France
Centre Léon Bérard

Lyon, 69008, France
Clinique Tessier

Valenciennes, 59300, France
Clinique des Cèdres

Cornebarrieu, 31700, France
Hôpital Foch

Suresnes, 92150, France
Institut Curie

Paris, 75005, France
Institut Curie

Saint-Cloud, 92210, France
Institut Sainte-Catherine

Avignon, 84918, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.